Omega-3 Insights

High doses of omega-3, particularly EPA, have shown potential in reducing cardiovascular risks, but the results are clouded by controversial study designs. While one trial demonstrated effectiveness with a pure EPA product, concerns linger about the validity of the placebo used. The complexity of treating nutrients like drugs raises questions about the expectations placed on omega-3 supplementation, especially in older populations already on multiple medications.